임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중· Diphtheria-Tetanus-acellular Pertussis VaccinesA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
리드: GSK
- 3상모집 중· Diphtheria-Tetanus-acellular Pertussis VaccinesA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
리드: GSK
- 1/2상모집 중· Respiratory Syncytial Virus Infections+MetapneumovirusA Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
리드: GSK
- 4상모집 중· Cardiovascular DiseaseRecombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
협력: GSK
- 2상모집 중· Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaA Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
협력: GSK
- 초기 1상모집 중· Chronic Myelomonocytic LeukemiaMomelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
협력: GSK
- 1상모집 중· Non-alcoholic Fatty Liver DiseaseA Study of Efimosfermin Alfa in Adults With Hepatic Impairment
리드: GSK
- 1상모집 중· Influenza, Human+COVID-19A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
리드: GSK
- 1상모집 중· Systemic Lupus ErythematosusA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
리드: GSK
- 1/2상모집 중· Gastrointestinal CancerA Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
협력: GSK
- 3상모집 중· Non-alcoholic Fatty Liver DiseaseA Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
리드: GSK
- 2상모집 중· Respiratory Syncytial Virus (RSV)Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
협력: GSK
- 3상모집 중· Gastrointestinal NeoplasmsA Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
리드: GSK
- 3상모집 중· Refractory Chronic CoughA 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
리드: GSK
- 단계 미표기모집 중· Diabetic NephropathiesTransformative Research in Diabetic Nephropathy 2.0
협력: 아스트라제네카, GSK, 노보노디스크, 리제네론, 로슈
- 2상모집 중· BronchiectasisA Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
리드: GSK
- 3상모집 중· Respiratory Syncytial Virus InfectionsA Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
리드: GSK
- 3상모집 중· Non-alcoholic Fatty Liver DiseaseA Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
리드: GSK
- 해당없음모집 중· Preventable Disease, VaccineAddressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies
협력: 아스트라제네카, GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
리드: GSK
- 2상모집 중· Alzheimer's DiseaseOpen-label Extension Study in Participants With Early Alzheimer's Disease
리드: GSK
- 3상모집 중· Neoplasms, LungA Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
리드: GSK
- 2상모집 중· Respiratory Syncytial Virus InfectionsA Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
리드: GSK
- 1/2상모집 중· Neoplasms, ProstateA Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
리드: GSK
- 2상모집 중· Myelodysplastic SyndromesA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
리드: GSK
- 2상모집 중· Pancreatic Adenocarcinoma MetastaticMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
협력: BMS, GSK
- 2상모집 중· Metabolic Dysfunction-Associated SteatohepatitisA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
리드: GSK
- 1/2상모집 중· Tumours, GynecologicalA Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
리드: GSK
- 2상모집 중· Primary MyelofibrosisStudy of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
리드: GSK
- 2상모집 중· Pancreas NeoplasmsDOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
협력: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.